Literature DB >> 16546176

TA205, an anti-talin monoclonal antibody, inhibits integrin-talin interaction.

Baodong Xing1, Shalini Thuppal, Arom Jedsadayanmata, Xiaoping Du, Stephen C-T Lam.   

Abstract

Talin mediates integrin signaling by binding to integrin cytoplasmic tails through its FERM domain which consists of F1, F2 and F3 subdomains. TA205, an anti-talin monoclonal antibody, disrupts actin stress fibers and focal adhesion when microinjected into fibroblasts. Here, we showed that TA205 caused an allosteric inhibition of integrin alphaIIb beta3 binding to the talin FERM domain and mapped the TA205 epitope to residues 131-150 in talin F1. Furthermore, binding of a talin rod fragment to talin head was partially inhibited by TA205. These findings suggest that talin F1 may be important in regulation of integrin binding and talin head-rod interaction.

Mesh:

Substances:

Year:  2006        PMID: 16546176     DOI: 10.1016/j.febslet.2006.02.077

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

Review 1.  Targeting Pyk2 for therapeutic intervention.

Authors:  Christopher A Lipinski; Joseph C Loftus
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

2.  Breaking down Leukemia Walls: Heteronemin, a Sesterterpene Derivative, Induces Apoptosis in Leukemia Molt4 Cells through Oxidative Stress, Mitochondrial Dysfunction and Induction of Talin Expression.

Authors:  Yu-Cheng Chen; Mei-Chin Lu; Mohamed El-Shazly; Kuei-Hung Lai; Tung-Ying Wu; Yu-Ming Hsu; Yi-Lun Lee; Yi-Chang Liu
Journal:  Mar Drugs       Date:  2018-06-17       Impact factor: 5.118

3.  Upregulation of Talin-1 expression associates with advanced pathological features and predicts lymph node metastases and biochemical recurrence of prostate cancer.

Authors:  Ning Xu; Hui-Jun Chen; Shao-Hao Chen; Xue-Yi Xue; Hong Chen; Qing-Shui Zheng; Yong Wei; Xiao-Dong Li; Jin-Bei Huang; Hai Cai; Xiong-Lin Sun
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.